An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled immunobridging study in Paraguay

Júlio Torales, Osmar Cuenca-Torres, Laurentino Barrios, Luis Armoa-Garcia, Gladys Estigarribia, Gabriela Sanabria, Meei‐Yun Lin, Josue Antonio Estrada, Lila Estephan, Hao‐Yuan Cheng, Charles Chen, Robert S. Janssen, Chia-En Lien